Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.57) per share. This is a 26.67 percent decrease over losses of $(0.45) per share from the same period last year.
Related Posts
‘@RobinhoodApp confirms @FoxBusiness report that Congress and regulators will have an uphill battle banning payment for order flow. PLUS why are @SECGov staffers throwing shade at @GaryGensler’ -Tweet From FOX’s Charlie Gasparino
https://twitter.com/CGasparino/status/1428443649361289225
Ossen Innovation 1H Sales $72.3M
Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (NASDAQ:OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel
Recap: Qudian Q1 Earnings
Shares of Qudian (NYSE:QD) fell 3.7% in pre-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share were up 156.00% year over year to $0.28, which missed the estimate of $0.29.